- Telescope Innovations Advances Self-Driving Lab Deployment, Strengthening Industry Impact – Telescope Innovations
- Telescope Innovations and Pfizer Sign Master Collaborative Research Agreement – Telescope Innovations
- Mettler Toledo and Telescope Innovations Agree to Globally Distribute Telescope’s Flagship Product, DirectInject-LC™ – Telescope Innovations
- Telescope Innovations Commences Trading on the Frankfurt Stock Exchange – Telescope Innovations
- Telescope Innovations Founder and CTO, Professor Jason Hein, Honoured with 2025 R. U. Lemieux Award – Telescope Innovations
- Second Nobel Prize Won by Telescope Innovations Advisor – Telescope Innovations
About Telescope Innovations
Telescope Innovations is a chemical technology company developing scalable manufacturing processes and tools for the pharmaceutical and chemical industry. The Company builds and deploys new enabling technologies including flexible robotic platforms and artificial intelligence software that improves experimental throughput, efficiency, and data quality. Our aim is to bring modern chemical technology solutions to meet the most serious challenges in health and sustainability.
About Virtual Investor Conferences®
Virtual Investor Conferences (VIC) is the leading proprietary investor conference series that provides an interactive forum for publicly traded companies to seamlessly present directly to investors.
Providing a real-time investor engagement solution, VIC is specifically designed to offer companies more efficient investor access. Replicating the components of an on-site investor conference, VIC offers companies enhanced capabilities to connect with investors, schedule targeted one-on-one meetings and enhance their presentations with dynamic video content. Accelerating the next level of investor engagement, Virtual Investor Conferences delivers leading investor communications to a global network of retail and institutional investors.
CONTACTS:
Telescope Innovations Corporation
Jeffrey W. Sherman, Ph.D.
Chief Commercial Officer
+1 443 454 7525
[email protected]
Virtual Investor Conferences
John M. Viglotti
SVP Corporate Services, Investor Access
OTC Markets Group
(212) 220-2221
[email protected]
